Abstract: | Objective To explore the role of clinical pharmacists in anti-infection treatment of morbidly obese patients with erysipelas. Methods Clinical pharmacists participated in the adjustment of anti-infection treatment drugs for the morbidly obese patient. According to the pharmacokinetic changes of the morbidly obese patient, combined with domestic and foreign literatures , it was suggested that the doses of anti-infective drugs for this patient were respectively: penicillin 4800000 IU ivd q6h, ceftriaxone 4g ivd qd, and levofloxacin 750mg ivd qd, which could be given to physicians as a reference. Results The follow-up advice of clinical pharmacists was adopted by physicians. Ultimately, clinical pharmacists assisted physicians to develop individual treatment programs, and the erysipelas infection was effectively controlled. Conclusion Clinical pharmacists should participate in the medical team of physicians and nurses to deliver better services to patients by finding key points to carry out pharmaceutical care and taking advantages of professional knowledge. What is more, this case also provided a reference for morbidly obese patients to adjust the dose of anti-infection |